Conduit Pharmaceuticals Inc. SC 13D/A Filing
Ticker: CDTTW · Form: SC 13D/A · Filed: Sep 19, 2024 · CIK: 1896212
| Field | Detail |
|---|---|
| Company | Conduit Pharmaceuticals Inc. (CDTTW) |
| Form Type | SC 13D/A |
| Filed Date | Sep 19, 2024 |
| Pages | 9 |
| Reading Time | 11 min |
| Key Dollar Amounts | $0.0001, $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a SC 13D/A filing submitted by Conduit Pharmaceuticals Inc. (ticker: CDTTW) to the SEC on Sep 19, 2024.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (me of Issuer) Common Stock, Par Value $0.0001 per share (Title of Class of Securiti); $0.001 (o the shares of common stock, par value $0.001 per share (“Common Stock”),).
How long is this filing?
Conduit Pharmaceuticals Inc.'s SC 13D/A filing is 9 pages with approximately 2,763 words. Estimated reading time is 11 minutes.
Where can I view the full SC 13D/A filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 2,763 words · 11 min read · ~9 pages · Grade level 10.6 · Accepted 2024-09-19 16:59:21
Key Financial Figures
- $0.0001 — me of Issuer) Common Stock, Par Value $0.0001 per share (Title of Class of Securiti
- $0.001 — o the shares of common stock, par value $0.001 per share (“Common Stock”),
Filing Documents
- formsc13da.htm (SC 13D/A) — 126KB
- ex-8.htm (EX-8) — 4KB
- ex-9.htm (EX-9) — 2KB
- ex-10.htm (EX-10) — 6KB
- ex-11.htm (EX-11) — 7KB
- ex-8_001.jpg (GRAPHIC) — 560KB
- ex-8_002.jpg (GRAPHIC) — 490KB
- ex-8_003.jpg (GRAPHIC) — 107KB
- ex-9_001.jpg (GRAPHIC) — 96KB
- ex-10_001.jpg (GRAPHIC) — 580KB
- ex-10_002.jpg (GRAPHIC) — 660KB
- ex-10_003.jpg (GRAPHIC) — 679KB
- ex-10_004.jpg (GRAPHIC) — 567KB
- ex-10_005.jpg (GRAPHIC) — 353KB
- ex-10_006.jpg (GRAPHIC) — 222KB
- ex-11_001.jpg (GRAPHIC) — 412KB
- ex-11_002.jpg (GRAPHIC) — 582KB
- ex-11_003.jpg (GRAPHIC) — 550KB
- ex-11_004.jpg (GRAPHIC) — 582KB
- ex-11_005.jpg (GRAPHIC) — 577KB
- ex-11_006.jpg (GRAPHIC) — 179KB
- ex-11_007.jpg (GRAPHIC) — 245KB
- 0001493152-24-037144.txt ( ) — 10394KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best knowledge and belief of the undersigned, each person certifies that the information set forth in this Date: September 19, 2024 Corvus Capital Ltd. By: /s/ Andrew Regan Andrew Regan Chief Executive Officer Date: September 19, 2024 Algo Holdings, Inc. By: /s/ Alexander Lambert Alexander Lambert Director Date: September 19, 2024 Andrew Regan /s/ Andrew Regan CUSIP NO. 20678X106 SCHEDULE 13D/A PAGE 9 OF 9 PAGES SCHEDULE A Transactions in the Shares of the Issuer by the Reporting Persons During the Past Sixty (60) Days The following table sets forth all transactions in the shares of Common Stock effected during the past sixty (60) days by the Reporting Persons. Except as noted below, all such transactions were effected in the open market through brokers and the price per share excludes commissions. Where a price range is provided in the column Price Range ($), the price reported in that row’s Price Per Share ($) column is a weighted average price. These shares of Common Stock were purchased or sold in multiple transactions at prices between the price ranges indicated in the Price Range ($) column. The Reporting Persons will undertake to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased or sold at each separate price. Trade Date Shares Purchased (Sold) Price Per Share ($) Price Range ($) 06/14/2024 1,100,000 (1) 0 (1) - 07/03/2024 (1,000) 0.64 - 07/08/2024 (35,923) 0.510 - 07/09/2024 (77,681) 0.4358 0.426-0.452 07/10/2024 (150,000) 0.3338 0.307-0.371 07/11/2024 (582,952) 0.2972 0.290-0.307 07/11/2024 (300,000) 0.29 0.279-0.307 07/12/2024 (1,389,820) 0.2471 0.266-0.303 07/15/2024 (1,005,200) 0.2471 0.223-0.276 07/16/2024 (10,244,392) 0.3169